Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wise

Showing results (381-390 of 822) with videos related to

Pageof 83
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1980
Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compoundsR Wise, J M Andrews, K A Bedford
Drugs|January 1, 1985
Pharmacokinetics and tissue penetration of temocillinM R Lockley, R M Brown, R Wise
The Journal of the Maine Medical Association|December 1, 1977
Electrocardiographic monitoring of cardiac arrhythmias in ambulatory patientsJ R Wise, K Tamm, W S Wilson
Lancet (London, England)|March 6, 1976
Letter: Tobramycin/cephalothin nephrotoxicityP Gillett, R Wise, V Melikian, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacinN P Brenwald, M J Gill, R Wise
The Journal of Antimicrobial Chemotherapy|May 1, 1979
The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acidR Wise, A P Gillett, J M Andrews
Surgical Endoscopy|May 10, 2003
Nissen fundoplication has a vagolytic effect on the lower esophageal sphincterB Sarani, T Chan, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillinsR Wise, J M Andrews, K A Bedford
Lancet (London, England)|December 14, 1996
Streptococcus pneumoniae resistance to fluoroquinolonesR Wise, N Brenwald, M Gill, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1988
Difco supplement C in MIC estimationsV M Andrews, J P Ashby, R Wise
Pageof 83

Showing results (381-390 of 822) with videos related to

Sort By:
Pageof 83
Antimicrobial Agents and Chemotherapy|May 1, 1980
Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compoundsR Wise, J M Andrews, K A Bedford
Drugs|January 1, 1985
Pharmacokinetics and tissue penetration of temocillinM R Lockley, R M Brown, R Wise
The Journal of the Maine Medical Association|December 1, 1977
Electrocardiographic monitoring of cardiac arrhythmias in ambulatory patientsJ R Wise, K Tamm, W S Wilson
Lancet (London, England)|March 6, 1976
Letter: Tobramycin/cephalothin nephrotoxicityP Gillett, R Wise, V Melikian, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacinN P Brenwald, M J Gill, R Wise
The Journal of Antimicrobial Chemotherapy|May 1, 1979
The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acidR Wise, A P Gillett, J M Andrews
Surgical Endoscopy|May 10, 2003
Nissen fundoplication has a vagolytic effect on the lower esophageal sphincterB Sarani, T Chan, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillinsR Wise, J M Andrews, K A Bedford
Lancet (London, England)|December 14, 1996
Streptococcus pneumoniae resistance to fluoroquinolonesR Wise, N Brenwald, M Gill, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1988
Difco supplement C in MIC estimationsV M Andrews, J P Ashby, R Wise
Pageof 83